MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

Detalles Bibliográficos
Autores principales: Bayley, Rachel, Blakemore, Daniel, García, Paloma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331017/
https://www.ncbi.nlm.nih.gov/pubmed/30680058
http://dx.doi.org/10.18632/oncotarget.26477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331017/
https://www.ncbi.nlm.nih.gov/pubmed/30680058
http://dx.doi.org/10.18632/oncotarget.26477

Ejemplares similares